Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2321646 Target Snapshot

Histone-lysine N-methyltransferase SETDB1 · SINGLE PROTEIN · Homo sapiens

103Compounds
60Assays
0Approved Drugs
31.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q15047. Use UniProt Q15047 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q15047 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone-lysine N-methyltransferase SETDB1 as ChEMBL target CHEMBL2321646, mapped to UniProt Q15047. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone-lysine N-methyltransferase SETDB1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2321646
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q15047
Histone-lysine N-methyltransferase SETDB1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone-lysine N-methyltransferase SETDB1 is the right protein anchor across sources, using UniProt Q15047 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistone-lysine N-methyltransferase SETDB1
UniProt AccessionQ15047
Component TypeProtein
Sequence Length1291 aa

Histone-lysine N-methyltransferase SETDB1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone-lysine N-methyltransferase SETDB1, mapped to UniProt Q15047. Sequence length is 1291 aa.

Mapped IDQ15047
Review nameHistone-lysine N-methyltransferase SETDB1
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5012.0
EC502.0
KD17.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5569118 7.1 Kd 80.0 Preclinical
CHEMBL4449143 6.68 Kd 210.0 Preclinical
CHEMBL5572139 6.63 Kd 232.0 Preclinical
CHEMBL4471748 5.8 Kd 1600.0 Preclinical
CHEMBL418052 5.66 IC50 2200.0 Preclinical
CHEMBL5564879 5.49 Kd 3260.0 Preclinical
CHEMBL4471746 5.36 Kd 4400.0 Preclinical
CHEMBL5572230 4.19 IC50 65000.0 Preclinical
CHEMBL4455427 2.6 Kd 2500000.0 Preclinical
CHEMBL4542222 2.57 Kd 2700000.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
2
5.5
0
6.0
2
6.5
2
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

60
Total Assays
16
Tested Compounds
2
Assay Types
Binding — 59 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 51 5 5.8
assay format 4 4 6.2
cell-based format 4 7 2.4
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine